Found: 16
Select item for more details and to access through your institution.
Neuroprotective Effects of Creatine in the CMVMJD135 Mouse Model of Spinocerebellar Ataxia Type 3.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 1, p. 100, doi. 10.1093/hmg/ddu422
- By:
- Publication type:
- Article
Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways.
- Published in:
- Human Molecular Genetics, 2011, v. 20, n. 15, p. 2996, doi. 10.1093/hmg/ddr203
- By:
- Publication type:
- Article
Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP 3 R2) Fails to Modify Disease Progression in a Mouse Model of Spinocerebellar Ataxia Type 3.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10606, doi. 10.3390/ijms241310606
- By:
- Publication type:
- Article
The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3’-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis.
- Published in:
- PLoS Genetics, 2015, v. 11, n. 1, p. 1, doi. 10.1371/journal.pgen.1004749
- By:
- Publication type:
- Article
P3‐152: NEURONAL MISSPLICING AND IMBALANCE IN TAU ISOFORM RATIO THROUGH ATXN3 MEDIATED DEUBIQUITYLATION: IMPLICATIONS FOR DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P990, doi. 10.1016/j.jalz.2019.06.3181
- By:
- Publication type:
- Article
Absence of Ataxin-3 Leads to Enhanced Stress Response in C. elegans.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018512
- By:
- Publication type:
- Article
Levetiracetam treatment leads to functional recovery after thoracic or cervical injuries of the spinal cord.
- Published in:
- NPJ Regenerative Medicine, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41536-021-00121-7
- By:
- Publication type:
- Article
Lithium Chloride Therapy Fails to Improve Motor Function in a Transgenic Mouse Model of Machado-Joseph Disease.
- Published in:
- Cerebellum, 2014, v. 13, n. 6, p. 713, doi. 10.1007/s12311-014-0589-9
- By:
- Publication type:
- Article
The Secretome of Bone Marrow and Wharton Jelly Derived Mesenchymal Stem Cells Induces Differentiation and Neurite Outgrowth in SH-SY5Y Cells.
- Published in:
- Stem Cells International, 2014, p. 1, doi. 10.1155/2014/438352
- By:
- Publication type:
- Article
Profiling Microglia in a Mouse Model of Machado–Joseph Disease.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 237, doi. 10.3390/biomedicines10020237
- By:
- Publication type:
- Article
Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3.
- Published in:
- Biomedicines, 2021, v. 9, n. 12, p. 1754, doi. 10.3390/biomedicines9121754
- By:
- Publication type:
- Article
Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
GSTpi Expression in MPTP-Induced Dopaminergic Neurodegeneration of C57BL/6 Mouse Midbrain and Striatum.
- Published in:
- Journal of Molecular Neuroscience, 2009, v. 38, n. 2, p. 114, doi. 10.1007/s12031-008-9141-z
- By:
- Publication type:
- Article
Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141610
- By:
- Publication type:
- Article
Correction: The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3'-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice